Results 21 to 30 of about 3,885,108 (382)

Comparison of the Effects of Sugammadex Recommended Dose (2 mg/kg) and Fixed Dose of 200 mg on the Reversal of Moderate Neuromuscular Block and Recovery Profile in Adult Patients [PDF]

Medicina
Background and Objectives: Neuromuscular blocking agents are essential to ensure optimal surgical conditions during general anesthesia. Sugammadex, a selective binding agent, is widely used to reverse neuromuscular blockade.
Ji-Yoon Jung, Sung-Ae Cho, Woojin Kwon, Hongwook Kim, Tae-Yun Sung   +4 more
doaj   +2 more sources

Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade With E-Learning: Protocol for the Multicenter Interrupted Time Series INVERT Study.

JMIR Res Protoc, 2017
Background Muscle relaxants facilitate endotracheal intubation under general anesthesia and improve surgical conditions. Residual neuromuscular blockade occurs when the patient is still partially paralyzed when awakened after surgery.
Thomsen JLD, Mathiesen O, Hägi-Pedersen D, Skovgaard LT, Østergaard D, Engbaek J, Gätke MR.   +6 more
europepmc   +2 more sources

A Quantitative Neuromuscular Blockade Monitor

Anesthesia & Analgesia, 1980
John P. Karis, Larry W. Burton, Joannes H. Karis   +2 more
openalex   +4 more sources

Neuromuscular monitoring: An assistant not an alternative.

Indian J Anaesth, 2018
Tak H, Prateek.
europepmc   +5 more sources

International survey of neuromuscular monitoring in two European countries: a questionnaire study among Hungarian and Romanian anaesthesiologists. [PDF]

Rom J Anaesth Intensive Care, 2019
Pongrácz A, Nemes R, Breazu C, Asztalos L, Mitre I, Tassonyi E, Fülesdi B, Mitre C.   +7 more
europepmc   +2 more sources

Neuromuscular monitoring and the cost of antagonism: when will we learn? [PDF]

Anaesthesia, 2017
Sorin J. Brull, Richard C. Prielipp
openalex   +2 more sources

2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade

Anesthesiology, 2023
These practice guidelines provide evidence-based recommendations on the management of neuromuscular monitoring and antagonism of neuromuscular blocking agents during and after general anesthesia.
S. Thilen, Wade A Weigel, M. Todd, R. Dutton, C. Lien, Stuart A. Grant, J. Szokol, L. Eriksson, M. Yaster, Mark D Grant, Madhulika Agarkar, A. Marbella, Jaime F. Blanck, K. Domino   +13 more
semanticscholar   +1 more source

Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative

Anesthesiology, 2022
Background: Residual neuromuscular blockade can be avoided with quantitative neuromuscular monitoring. The authors embarked on a professional practice initiative to attain documented train-of-four ratios greater than or equal to 0.90 in all patients for ...
Wade A Weigel, Barbara L. Williams, N. Hanson, C. C. Blackmore, Randy L Johnson, Gary M Nissen, Andrew James, Wyndam M. Strodtbeck   +7 more
semanticscholar   +1 more source

Spinal Surgery- Use of Dexmedetomidine for Myasthenia Gravis - A Case Report [PDF]

Liaquat National Journal of Primary Care, 2020
Myasthenia gravis (MG) is a chronic autoimmune disease in which autoantibodies destroy acetylcholine receptors at motor end plat of neuromuscular junction which prevent skeletal muscle depolarization and contraction, causes muscle weakness and tiredness
Nighat Abbas, Syed Sajjad Alam, Muhammad Rafique, Sumayya Kausar, Anees ur Rehman, Sarosh ul Hassan   +5 more
doaj   +1 more source

Reversal agent is mandatory even with neuromuscular monitoring!

Indian J Anaesth, 2018
Mehandale SG, Bangera A, Thiyath SV.
europepmc   +2 more sources